209 related articles for article (PubMed ID: 2434508)
21. Permeability of a heparin-polyvinyl alcohol hydrogel to thrombin and antithrombin III.
Smith BA; Sefton MV
J Biomed Mater Res; 1988 Aug; 22(8):673-85. PubMed ID: 3215905
[TBL] [Abstract][Full Text] [Related]
22. Binding of fibrin monomer and heparin to thrombin in a ternary complex alters the environment of the thrombin catalytic site, reduces affinity for hirudin, and inhibits cleavage of fibrinogen.
Hogg PJ; Jackson CM; Labanowski JK; Bock PE
J Biol Chem; 1996 Oct; 271(42):26088-95. PubMed ID: 8824251
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of anticoagulant effects of some sulphated polysaccharides.
Andersson LO; Hoffman J; Holmer E; Larm O; Larsson K; Söderström G
Thromb Res; 1982 Dec; 28(6):741-7. PubMed ID: 6132465
[TBL] [Abstract][Full Text] [Related]
24. Tryptophan 60-D in the B-insertion loop of thrombin modulates the thrombin-antithrombin reaction.
Rezaie AR
Biochemistry; 1996 Feb; 35(6):1918-24. PubMed ID: 8639675
[TBL] [Abstract][Full Text] [Related]
25. Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin III.
Danishefsky I; Ahrens M; Klein S
Biochim Biophys Acta; 1977 Jun; 498(1):215-22. PubMed ID: 560216
[TBL] [Abstract][Full Text] [Related]
26. Heparin-like tubings. III. Kinetics and mechanism of thrombin, antithrombin III and thrombin-antithrombin complex adsorption under controlled-flow conditions.
Migonney V; Fougnot C; Jozefowicz M
Biomaterials; 1988 Sep; 9(5):413-8. PubMed ID: 3224126
[TBL] [Abstract][Full Text] [Related]
27. Molecular weight analysis of antithrombin III-heparin and antithrombin III-thrombin-heparin complexes.
Pletcher CH; Cunningham MT; Nelsestuen GL
J Biol Chem; 1986 Mar; 261(9):4143-7. PubMed ID: 3949807
[TBL] [Abstract][Full Text] [Related]
28. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
[TBL] [Abstract][Full Text] [Related]
29. The heparin-accelerated neutralisation of bovine alpha and beta thrombins by antithrombin III.
MacGregor IR; Lane DA; Kakkar VV
Biochim Biophys Acta; 1980 Sep; 632(1):131-7. PubMed ID: 7417517
[TBL] [Abstract][Full Text] [Related]
30. An automated approach to characterize, in simple kinetic terms, the generation and inactivation of thrombin and the interaction of fibrinogen with thrombin.
Hoak DR; Banerjee SK; Kaldor G
Clin Chem; 1988 Oct; 34(10):1971-5. PubMed ID: 3168206
[TBL] [Abstract][Full Text] [Related]
31. Change of viscoelastic property and morphology of fibrin affected by antithrombin III and heparin: QCM-Z and AFM study.
Jung H; Tae G; Kim YH; Johannsmann D
Colloids Surf B Biointerfaces; 2009 Jan; 68(1):111-9. PubMed ID: 19004623
[TBL] [Abstract][Full Text] [Related]
32. Kinetic study on the initial stage of the fibrinogen-fibrin conversion by thrombin. (II) Application of enzyme kinetics to turbidimetrical method.
Sato H; Nakajima A
Thromb Res; 1984 Jul; 35(2):133-9. PubMed ID: 6474414
[TBL] [Abstract][Full Text] [Related]
33. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
[TBL] [Abstract][Full Text] [Related]
34. [Inducing conformational changes in thrombin by ligands as a way of regulating its activity].
Gershkovich AA
Biokhimiia; 1996 Jul; 61(7):1139-51. PubMed ID: 9035728
[TBL] [Abstract][Full Text] [Related]
35. Abolition by dextran sulfate of the heparin-accelerated antithrombin III/thrombin reaction.
Oshima G; Nagai T; Nagasawa K
Thromb Res; 1984 Sep; 35(6):601-11. PubMed ID: 6209818
[TBL] [Abstract][Full Text] [Related]
36. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
37. Binding of antithrombin III and thrombin to immobilized heparin under flow conditions.
Byun Y; Jacobs HA; Kim SW
Biotechnol Prog; 1996; 12(2):217-25. PubMed ID: 8857192
[TBL] [Abstract][Full Text] [Related]
38. Structural and functional properties of human alpha-thrombin, phosphopyridoxylated alpha-thrombin, and gamma T-thrombin. Identification of lysyl residues in alpha-thrombin that are critical for heparin and fibrin(ogen) interactions.
Church FC; Pratt CW; Noyes CM; Kalayanamit T; Sherrill GB; Tobin RB; Meade JB
J Biol Chem; 1989 Nov; 264(31):18419-25. PubMed ID: 2509458
[TBL] [Abstract][Full Text] [Related]
39. Heparin-like functionalized polymer surfaces: discrimination between catalytic and adsorption processes during the course of thrombin inhibition.
Charef S; Tapon-Bretaudière J; Fischer AM; Pflüger F; Jozefowicz M; Labarre D
Biomaterials; 1996 May; 17(9):903-12. PubMed ID: 8718936
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial cells on two-and three-dimensional fibrin assemblies for biomaterial coatings.
Filová E; Brynda E; Riedel T; Bacáková L; Chlupác J; Lisá V; Houska M; Dyr JE
J Biomed Mater Res A; 2009 Jul; 90(1):55-69. PubMed ID: 18481789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
